Mixed Topics
From the Journals
Hospital Readmissions Reduction Program may be doing more harm than good
Thirty-day postdischarge mortality went up after the program for some, down for others.
From the Journals
Invasive strategy increased bleeding risk in frail older AMI patients
Registry analysis suggests frailty in an AMI patient calls for personalized decision making.
Conference Coverage
‘Organoid technology’ poised to transform cancer care
BOSTON – Clinical trials may one day be conducted in a petri dish.
Feature
Palliative care update highlights role of nonspecialists
The latest guideline revision aims to establish a foundation for “gold-standard” palliative care.
Conference Coverage
Septic shock: Innovative treatment options in the wings
BOSTON - Trials evaluating vitamin C for refractory septic shock have demonstrated a large mortality impact.
From the Journals
Admission eosinopenia predicted severe CDI outcomes
Significant predictors of mortality included having more comorbidities and lower systolic blood pressure at admission.
Conference Coverage
Review protocols, follow reprocessing guidelines to cut device-related HAIs
Environmental pathogens associated with medical devices or device reprocessing are often the cause of HAI-related investigations.
News
FDA approves first EpiPen generic
The approval is for the generic version of the most widely prescribed epinephrine autoinjector in the United States.
Conference Coverage
French warn of upsurge in pneumococcal meningitis
MALMO, SWEDEN – Culprit is emergence of serotype 24F, not covered by PCV13.
News
FDA warns against azithromycin in blood or lymph node cancers
Azithromycin can lead to relapse and death when used to prevent an inflammatory lung condition in patients with blood or lymph node cancers who...